Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 1;106(5):e275-e276.
doi: 10.1097/TP.0000000000004087. Epub 2022 Mar 8.

Casirivimab-imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients

Chloé Dimeglio  1   2   3 , Arnaud Del Bello  2   4 , Sabine Chapuy-Regaud  1   2   3 , Laure Esposito  4 , Chloé Danet  5 , Chloé Couat  4 , Jacques Izopet  1   2   3 , Nassim Kamar  2   3   4
Affiliations

Casirivimab-imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients

Chloé Dimeglio et al. Transplantation. .

Abstract

formula image

PubMed Disclaimer

Conflict of interest statement

The authors declare no funding or conflicts of interest.

References

    1. O’Brien MP, Forleo-Neto E, Musser BJ, et al. ; Covid-19 Phase 3 Prevention Trial Team. Subcutaneous REGEN-COV antibody combination to prevent Covid-19. N Engl J Med. 2021;385:1184–1195. - PMC - PubMed
    1. Kamar N, Abravanel F, Marion O, et al. . Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661–662. - PMC - PubMed
    1. Hall VG, Ferreira VH, Ku T, et al. . Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients. N Engl J Med. 2021;385:1244–1246. - PMC - PubMed
    1. National French Health Authority. RONAPREVE (casirivimab-imdevimab) (prophylaxie pré-exposition de l’infection à SARS-CoV-2). Available at https://www.has-sante.fr/jcms/p_3281544/fr/ronapreve-casirivimab-imdevim.... Accessed August 6, 2021.
    1. Dimeglio C, Herin F, Martin-Blondel G, et al. . Antibody titers and protection against a SARS-CoV-2 infection. J Infect. 2021;84:248–288. - PMC - PubMed